Nirvana Life Sciences Inc. (CSE:NIRV)
Canada flag Canada · Delayed Price · Currency is CAD
0.1050
-0.1950 (-65.00%)
Apr 1, 2025, 5:05 PM EST

Nirvana Life Sciences Ratios and Metrics

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Apr '24 Apr '23 Apr '22 Apr '21
Market Capitalization
1214-
Market Cap Growth
11.11%136.21%-74.83%--
Enterprise Value
1214-
Last Close Price
0.100.500.305.70-
PB Ratio
-1.81-2.12-1.09-25.10-
Debt / Equity Ratio
-0.07-0.02-0.06--
Quick Ratio
0.020.020.030.0834.85
Current Ratio
0.020.020.070.2242.41
Return on Equity (ROE)
----1105.54%-
Return on Assets (ROA)
-200.02%-1001.10%-264.67%-86.15%-
Return on Capital (ROIC)
----142.24%-
Earnings Yield
-107.36%-36.15%-145.67%-139.42%-
FCF Yield
-2.06%-7.87%-32.64%-12.09%-
Buyback Yield / Dilution
-4.54%-37.61%7.05%-5.19%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.